Table 2
Open in new tab

Multivariable adjusted logistic regression for treatment with induction and surgery

CharacteristicsOdds ratio (95% confidence interval)
Histology
 Adenocarcinoma1.00 (Reference)
 Squamous cell0.48 (0.35, 0.65)
AJCC Stage
 Stage II1.00 (Reference)
 Stage III0.78 (0.64, 0.96)
Age at diagnosis (years)
 66–691.00 (Reference)
 70–740.63 (0.49, 0.80)
 75–790.43 (0.33, 0.57)
 80+0.09 (0.06, 0.13)
Sex
 Male1.00 (Reference)
 Female0.84 (0.64, 1.11)
Race
 White1.00 (Reference)
 Black0.52 (0.29, 0.93)
 Other1.27 (0.76, 2.11)
Marital status
 Married1.00 (Reference)
 Not married/Unknown0.59 (0.47, 0.74)
Charlson comorbidity index
 01.00 (Reference)
 10.84 (0.66, 1.07)
 2+0.51 (0.39, 0.67)
Tumor location
 Esophagus NOS1.00 (Reference)
 Distal esophagus and gastroesophageal junction (GEJ)2.52 (1.57, 4.05)
 Middle third/thoracic1.38 (0.80, 2.38)
Residence
 Metro1.00 (Reference)
 Non-metro1.31 (0.99, 1.72)
Year with respect to NCCN Guideline publication
 Low SES (< 80% in census district)
 Pre-NCCN Guideline publication1.00 (Reference)
 Post-NCCN Guideline publication1.78 (1.05, 3.03)
 High SES (> = 80% in census district)
 Pre- NCCN Guideline publication1.00 (Reference)
 Post- NCCN Guideline publication1.20 (0.93, 1.55)
CharacteristicsOdds ratio (95% confidence interval)
Histology
 Adenocarcinoma1.00 (Reference)
 Squamous cell0.48 (0.35, 0.65)
AJCC Stage
 Stage II1.00 (Reference)
 Stage III0.78 (0.64, 0.96)
Age at diagnosis (years)
 66–691.00 (Reference)
 70–740.63 (0.49, 0.80)
 75–790.43 (0.33, 0.57)
 80+0.09 (0.06, 0.13)
Sex
 Male1.00 (Reference)
 Female0.84 (0.64, 1.11)
Race
 White1.00 (Reference)
 Black0.52 (0.29, 0.93)
 Other1.27 (0.76, 2.11)
Marital status
 Married1.00 (Reference)
 Not married/Unknown0.59 (0.47, 0.74)
Charlson comorbidity index
 01.00 (Reference)
 10.84 (0.66, 1.07)
 2+0.51 (0.39, 0.67)
Tumor location
 Esophagus NOS1.00 (Reference)
 Distal esophagus and gastroesophageal junction (GEJ)2.52 (1.57, 4.05)
 Middle third/thoracic1.38 (0.80, 2.38)
Residence
 Metro1.00 (Reference)
 Non-metro1.31 (0.99, 1.72)
Year with respect to NCCN Guideline publication
 Low SES (< 80% in census district)
 Pre-NCCN Guideline publication1.00 (Reference)
 Post-NCCN Guideline publication1.78 (1.05, 3.03)
 High SES (> = 80% in census district)
 Pre- NCCN Guideline publication1.00 (Reference)
 Post- NCCN Guideline publication1.20 (0.93, 1.55)
Table 2
Open in new tab

Multivariable adjusted logistic regression for treatment with induction and surgery

CharacteristicsOdds ratio (95% confidence interval)
Histology
 Adenocarcinoma1.00 (Reference)
 Squamous cell0.48 (0.35, 0.65)
AJCC Stage
 Stage II1.00 (Reference)
 Stage III0.78 (0.64, 0.96)
Age at diagnosis (years)
 66–691.00 (Reference)
 70–740.63 (0.49, 0.80)
 75–790.43 (0.33, 0.57)
 80+0.09 (0.06, 0.13)
Sex
 Male1.00 (Reference)
 Female0.84 (0.64, 1.11)
Race
 White1.00 (Reference)
 Black0.52 (0.29, 0.93)
 Other1.27 (0.76, 2.11)
Marital status
 Married1.00 (Reference)
 Not married/Unknown0.59 (0.47, 0.74)
Charlson comorbidity index
 01.00 (Reference)
 10.84 (0.66, 1.07)
 2+0.51 (0.39, 0.67)
Tumor location
 Esophagus NOS1.00 (Reference)
 Distal esophagus and gastroesophageal junction (GEJ)2.52 (1.57, 4.05)
 Middle third/thoracic1.38 (0.80, 2.38)
Residence
 Metro1.00 (Reference)
 Non-metro1.31 (0.99, 1.72)
Year with respect to NCCN Guideline publication
 Low SES (< 80% in census district)
 Pre-NCCN Guideline publication1.00 (Reference)
 Post-NCCN Guideline publication1.78 (1.05, 3.03)
 High SES (> = 80% in census district)
 Pre- NCCN Guideline publication1.00 (Reference)
 Post- NCCN Guideline publication1.20 (0.93, 1.55)
CharacteristicsOdds ratio (95% confidence interval)
Histology
 Adenocarcinoma1.00 (Reference)
 Squamous cell0.48 (0.35, 0.65)
AJCC Stage
 Stage II1.00 (Reference)
 Stage III0.78 (0.64, 0.96)
Age at diagnosis (years)
 66–691.00 (Reference)
 70–740.63 (0.49, 0.80)
 75–790.43 (0.33, 0.57)
 80+0.09 (0.06, 0.13)
Sex
 Male1.00 (Reference)
 Female0.84 (0.64, 1.11)
Race
 White1.00 (Reference)
 Black0.52 (0.29, 0.93)
 Other1.27 (0.76, 2.11)
Marital status
 Married1.00 (Reference)
 Not married/Unknown0.59 (0.47, 0.74)
Charlson comorbidity index
 01.00 (Reference)
 10.84 (0.66, 1.07)
 2+0.51 (0.39, 0.67)
Tumor location
 Esophagus NOS1.00 (Reference)
 Distal esophagus and gastroesophageal junction (GEJ)2.52 (1.57, 4.05)
 Middle third/thoracic1.38 (0.80, 2.38)
Residence
 Metro1.00 (Reference)
 Non-metro1.31 (0.99, 1.72)
Year with respect to NCCN Guideline publication
 Low SES (< 80% in census district)
 Pre-NCCN Guideline publication1.00 (Reference)
 Post-NCCN Guideline publication1.78 (1.05, 3.03)
 High SES (> = 80% in census district)
 Pre- NCCN Guideline publication1.00 (Reference)
 Post- NCCN Guideline publication1.20 (0.93, 1.55)
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close